These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells. Hamill P; Jean F Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392 [TBL] [Abstract][Full Text] [Related]
3. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex. Sali DL; Ingram R; Wendel M; Gupta D; McNemar C; Tsarbopoulos A; Chen JW; Hong Z; Chase R; Risano C; Zhang R; Yao N; Kwong AD; Ramanathan L; Le HV; Weber PC Biochemistry; 1998 Mar; 37(10):3392-401. PubMed ID: 9521660 [TBL] [Abstract][Full Text] [Related]
4. Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products. Ingallinella P; Altamura S; Bianchi E; Taliani M; Ingenito R; Cortese R; De Francesco R; Steinkühler C; Pessi A Biochemistry; 1998 Jun; 37(25):8906-14. PubMed ID: 9636032 [TBL] [Abstract][Full Text] [Related]
5. Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies. Cicero DO; Barbato G; Koch U; Ingallinella P; Bianchi E; Nardi MC; Steinkühler C; Cortese R; Matassa V; De Francesco R; Pessi A; Bazzo R J Mol Biol; 1999 Jun; 289(2):385-96. PubMed ID: 10366512 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C NS3 protease: restoration of NS4A cofactor activity by N-biotinylation of mutated NS4A using synthetic peptides. Butkiewicz NJ; Yao N; Wright-Minogue J; Zhang R; Ramanathan L; Lau JY; Hong Z; Dasmahapatra B Biochem Biophys Res Commun; 2000 Jan; 267(1):278-82. PubMed ID: 10623610 [TBL] [Abstract][Full Text] [Related]
8. Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 A resolution structure in a hexagonal crystal form. Yan Y; Li Y; Munshi S; Sardana V; Cole JL; Sardana M; Steinkuehler C; Tomei L; De Francesco R; Kuo LC; Chen Z Protein Sci; 1998 Apr; 7(4):837-47. PubMed ID: 9568891 [TBL] [Abstract][Full Text] [Related]
9. Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease. Liverton NJ; Holloway MK; McCauley JA; Rudd MT; Butcher JW; Carroll SS; DiMuzio J; Fandozzi C; Gilbert KF; Mao SS; McIntyre CJ; Nguyen KT; Romano JJ; Stahlhut M; Wan BL; Olsen DB; Vacca JP J Am Chem Soc; 2008 Apr; 130(14):4607-9. PubMed ID: 18338894 [TBL] [Abstract][Full Text] [Related]
10. Product inhibition of the hepatitis C virus NS3 protease. Steinkühler C; Biasiol G; Brunetti M; Urbani A; Koch U; Cortese R; Pessi A; De Francesco R Biochemistry; 1998 Jun; 37(25):8899-905. PubMed ID: 9636031 [TBL] [Abstract][Full Text] [Related]
11. The design and enzyme-bound crystal structure of indoline based peptidomimetic inhibitors of hepatitis C virus NS3 protease. Ontoria JM; Di Marco S; Conte I; Di Francesco ME; Gardelli C; Koch U; Matassa VG; Poma M; Steinkühler C; Volpari C; Harper S J Med Chem; 2004 Dec; 47(26):6443-6. PubMed ID: 15588076 [TBL] [Abstract][Full Text] [Related]
12. Structural characterization of the Hepatitis C Virus NS3 protease from genotype 3a: the basis of the genotype 1b vs. 3a inhibitor potency shift. Gallo M; Bottomley MJ; Pennestri M; Eliseo T; Paci M; Koch U; Bazzo R; Summa V; Carfì A; Cicero DO Virology; 2010 Sep; 405(2):424-38. PubMed ID: 20630554 [TBL] [Abstract][Full Text] [Related]
13. In-cell selectivity profiling of membrane-anchored and replicase-associated hepatitis C virus NS3-4A protease reveals a common, stringent substrate recognition profile. Martin MM; Condotta SA; Fenn J; Olmstead AD; Jean F Biol Chem; 2011 Oct; 392(10):927-35. PubMed ID: 21749281 [TBL] [Abstract][Full Text] [Related]
14. The RNA aptamer-binding site of hepatitis C virus NS3 protease. Hwang J; Fauzi H; Fukuda K; Sekiya S; Kakiuchi N; Shimotohno K; Taira K; Kusakabe I; Nishikawa S Biochem Biophys Res Commun; 2000 Dec; 279(2):557-62. PubMed ID: 11118325 [TBL] [Abstract][Full Text] [Related]
15. [Hepatitis C virus NS3/4A with different secondary structures at amino-terminus has different serine protease activities and inhibitory activities on host cell]. Wang XP; Li FJ; Deng L; Nagano-Fujii M; An C; Jiang D; Kitayama K; Hotta H Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(37):2649-53. PubMed ID: 20137685 [TBL] [Abstract][Full Text] [Related]
16. A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals. Franco S; Clotet B; Martínez MA Virus Res; 2008 Feb; 131(2):260-70. PubMed ID: 18037183 [TBL] [Abstract][Full Text] [Related]
17. Single-cell resolution imaging of membrane-anchored hepatitis C virus NS3/4A protease activity. Martin MM; Jean F Biol Chem; 2006 Aug; 387(8):1075-80. PubMed ID: 16895477 [TBL] [Abstract][Full Text] [Related]
18. Mapping natural polymorphisms of hepatitis C virus NS3/4A protease and antiviral resistance to inhibitors in worldwide isolates. López-Labrador FX; Moya A; Gonzàlez-Candelas F Antivir Ther; 2008; 13(4):481-94. PubMed ID: 18672527 [TBL] [Abstract][Full Text] [Related]
19. [Detection of proteolytic activity of hepatitis C virus NS3-4A protease using enzymelinked immunosorbent assay]. Chen X; Guo J; Chen H; Wanglin Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Jun; 22(3):300-2. PubMed ID: 12903484 [TBL] [Abstract][Full Text] [Related]
20. Development of a cell-based assay for monitoring hepatitis C virus ns3/4a protease activity. Lei YF; Yin W; Yang J; Lv X; Wei SH; An QX; Hu XB; Xu ZK Acta Virol; 2008; 52(3):133-41. PubMed ID: 18999887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]